[155] Patients should be counseled that while some improvement may be noticed early in treatment, optimal therapeutic benefit may take time to develop

Injectable GLP-1s: Nearly 100% bioavailability Consistent, predictable absorption Doses of 1-2.4mg weekly for semaglutide FDA-Approved Oral Tablets: 0.4-1% bioavailability Requires 7-25mg doses to achieve similar effects Must be taken with specific timing and fasting requirements Compounded ODT Formulations: Theoretical bioavailability advantage over swallowed tablets Sublingual/buccal delivery bypasses stomach acid and first-pass metabolism However, research on peptide delivery shows challenges: peptides may be degraded by salivary enzymes, have poor permeability due to large molecular size, and face continuous wash-away from saliva No clinical trials have established actual bioavailability or effectiveness for compounded GLP-1 ODTs These formulations are not FDA-approved and haven't undergone rigorous testing The theoretical advantage of ODT formulations is that by dissolving in the mouth rather than the stomach, they could achieve better absorption than swallowed tablets while maintaining the convenience of a daily, needle-free option

No Comments How Long Do You Stay on Semaglutide for Weight Loss
Never attempt to combine partial doses from different pens
Whether you need ongoing support, customized nutrition guidance, or alternative weight management solutions, were here to help you achieve long-term success
Studies have shown that after 68 weeks (12 to 15 months) of Wegovy treatment, average weight loss is to the tune of 15% of the starting body weight